GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results

Provided By Globe Newswire

Last update: Mar 28, 2023

BOSTON, March 28, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today reported operational highlights and financial results for the fourth quarter and full year ended December 31, 2022.